Showing results (291-300 of 523) with videos related to
Sort By:
Pageof 53
Pediatric Blood & Cancer|April 21, 2021
Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsTeresa Stachowicz-Stencel, Anna Synakiewicz, Marianna Cornet, et al.Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.Cancer Treatment Reviews|August 23, 2022
Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time biasMaria Kfoury, Marie Najean, Ariane Lappara, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2016
Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in FranceClaire Rivoisy, Benjamin Besse, Nicolas Girard, et al.European Journal of Cancer (Oxford, England : 1990)|February 9, 2023
Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancerAdrien Rousseau, Marco Tagliamento, Edouard Auclin, et al.Annales De Pathologie|March 18, 2014
[Rythmic-pathology: the French national pathology network for thymic epithelial tumours]Lara Chalabreysse, Vincent Thomas De Montpreville, Anne De Muret, et al.European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinionLizza E L Hendriks, Christophe Dooms, Thierry Berghmans, et al.Journal of Thoracic Disease|September 4, 2018
Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid EGFR/KRAS analysis in 43 casesMaria-Rosa Ghigna, Adrian Crutu, Valentina Florea, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancerLecia V Sequist, Benjamin Besse, Thomas J Lynch, et al.Respiratory Medicine and Research|April 23, 2023
Outcomes of extended resection for locally advanced thymic malignanciesJean Baptiste Menager, Olaf Mercier, Antonin Levy, et al.Pageof 53